Michael Parsons
Papers
1
Total Citations
100
H-Index
1
About
Michael Parsons is a pioneering chemical biologist whose work bridges high-throughput screening and developmental biology to tackle metabolic disease. His most influential contribution is the development of automated reporter-based screening in zebrafish, enabling the first quantitative high-throughput in vivo screen for compounds that increase pancreatic β-cell mass—a breakthrough with profound implications for diabetes therapy. This landmark 2015 study, cited over 100 times, demonstrated that whole-organism screening can overcome the bottlenecks of in vitro assays by capturing complex physiological responses. By adapting HTS principles to a vertebrate model, Parsons opened new avenues for drug discovery, allowing researchers to identify novel pathways regulating β-cell proliferation in a living system. His work has been instrumental in shifting the field toward more predictive, in vivo approaches for identifying regenerative therapies. With a career focused on integrating chemical genetics, zebrafish biology, and high-content imaging, Parsons continues to drive innovation in the search for treatments that restore functional β-cell mass, making him a key figure at the intersection of chemical biology and diabetes research.
Research Focus
Key Achievements
Top Papers
- 1